EA200300842A1 - Новая соль тиазолидиндиона и ее полиморфные формы в качестве противодиабетических средств и способ их получения - Google Patents

Новая соль тиазолидиндиона и ее полиморфные формы в качестве противодиабетических средств и способ их получения

Info

Publication number
EA200300842A1
EA200300842A1 EA200300842A EA200300842A EA200300842A1 EA 200300842 A1 EA200300842 A1 EA 200300842A1 EA 200300842 A EA200300842 A EA 200300842A EA 200300842 A EA200300842 A EA 200300842A EA 200300842 A1 EA200300842 A1 EA 200300842A1
Authority
EA
Eurasian Patent Office
Prior art keywords
polymorphic forms
thiazolidindion
diabetic
preparation
new salt
Prior art date
Application number
EA200300842A
Other languages
English (en)
Inventor
Хуан Карлос Дель Кастильо Нието
Франциско Маркильяс Олондрис
Элизабет Де Рамон Амат
Original Assignee
Лабораториос Вита, С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Лабораториос Вита, С.А. filed Critical Лабораториос Вита, С.А.
Publication of EA200300842A1 publication Critical patent/EA200300842A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Данное изобретение относится к новой соли 5-(4-{2-[(6-метоксипиримидин-4-ил)метиламино]этокси}бензил)тиазолидин-2,4-диона и ее полиморфным формам, которые обладают высокой гипергликемической активностью и которые поэтому потенциально пригодны для лечения и/или профилактики диабета и/или других изменений или компликаций, свойственных диабету, таких как гипергликемия или гиперлипидемия. Данное изобретение также относится к способу их получения.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200300842A 2001-01-31 2002-01-21 Новая соль тиазолидиндиона и ее полиморфные формы в качестве противодиабетических средств и способ их получения EA200300842A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200100273A ES2174748B1 (es) 2001-01-31 2001-01-31 Nueva sal de tiazolidindiona y sus polimorfos como agentes antidiabeticos y procedimiento para la obtencion de los mismos.
PCT/IB2002/000229 WO2002060899A1 (en) 2001-01-31 2002-01-21 New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them

Publications (1)

Publication Number Publication Date
EA200300842A1 true EA200300842A1 (ru) 2004-04-29

Family

ID=8496644

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300842A EA200300842A1 (ru) 2001-01-31 2002-01-21 Новая соль тиазолидиндиона и ее полиморфные формы в качестве противодиабетических средств и способ их получения

Country Status (27)

Country Link
US (1) US20040106632A1 (ru)
EP (1) EP1355908A1 (ru)
JP (1) JP2004529870A (ru)
KR (1) KR20030078893A (ru)
CN (1) CN1694881A (ru)
AP (1) AP1281A (ru)
AR (1) AR042584A1 (ru)
BG (1) BG108047A (ru)
BR (1) BR0206850A (ru)
CA (1) CA2436556A1 (ru)
CZ (1) CZ20032015A3 (ru)
EA (1) EA200300842A1 (ru)
EE (1) EE200300356A (ru)
ES (1) ES2174748B1 (ru)
HU (1) HUP0302871A2 (ru)
IL (1) IL157028A0 (ru)
IS (1) IS6896A (ru)
MA (1) MA26988A1 (ru)
MX (1) MXPA03006722A (ru)
NO (1) NO20033375L (ru)
NZ (1) NZ527677A (ru)
PE (1) PE20020969A1 (ru)
PL (1) PL362527A1 (ru)
SK (1) SK9552003A3 (ru)
WO (1) WO2002060899A1 (ru)
YU (1) YU60303A (ru)
ZA (1) ZA200305873B (ru)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
CN1183130C (zh) * 1999-09-24 2005-01-05 中国人民解放军军事医学科学院毒物药物研究所 噻唑烷类衍生物及其医药用途
ES2156574B1 (es) * 1999-11-18 2002-02-01 Vita Invest Sa Nuevos derivados de tiazolidindiona como agentes antidiabeticos

Also Published As

Publication number Publication date
AP1281A (en) 2004-05-25
ZA200305873B (en) 2004-07-30
YU60303A (sh) 2006-05-25
BG108047A (bg) 2004-08-31
BR0206850A (pt) 2004-01-13
ES2174748B1 (es) 2003-09-16
NZ527677A (en) 2005-01-28
WO2002060899A1 (en) 2002-08-08
MA26988A1 (fr) 2004-12-20
NO20033375L (no) 2003-08-22
CZ20032015A3 (cs) 2004-02-18
US20040106632A1 (en) 2004-06-03
EP1355908A1 (en) 2003-10-29
MXPA03006722A (es) 2004-10-15
ES2174748A1 (es) 2002-11-01
AP2003002832A0 (en) 2003-09-30
CN1694881A (zh) 2005-11-09
NO20033375D0 (no) 2003-07-28
IL157028A0 (en) 2004-02-08
PE20020969A1 (es) 2002-12-04
EE200300356A (et) 2003-10-15
PL362527A1 (en) 2004-11-02
IS6896A (is) 2003-07-28
JP2004529870A (ja) 2004-09-30
KR20030078893A (ko) 2003-10-08
HUP0302871A2 (hu) 2003-12-29
AR042584A1 (es) 2005-06-29
SK9552003A3 (en) 2004-05-04
CA2436556A1 (en) 2002-08-08

Similar Documents

Publication Publication Date Title
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
EA201200954A1 (ru) Способ получения полугидрата гидрохлорида (r)-8-хлор-1-метил-2,3,4,5-тетрагидро-1н-3-бензазепина, фармацевтическая композиция на его основе и его применение
ATE523504T1 (de) 1-thio-d-glucitolderivate
WO2005112953A3 (en) Treatment of hypercholesterolemia, hypertriglyceridemia and cardiovascular-related conditions using phosphalipase-a2 inhibitors
WO2006127503A3 (en) Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
ATE260906T1 (de) Neue heterocyclische analoge von diphenylethylenverbindungen
BRPI0516904A (pt) processo para a preparação de um derivado de 2-etilaminopiridina e composto
ATE293119T1 (de) Cardioprotektive phosphonate
EA200701364A1 (ru) Композиции слитых белков-аналогов glp-1
IL180985A0 (en) N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy}benzamidine 2 methanesulfonic acid salt
BG108225A (en) Thiohydantoins and use thereof for treating diabetes
EA200400491A1 (ru) Полиморфная форма римонабанта, способ её получения и содержащие её фармацевтические композиции
WO2007136640A3 (en) Processes for the preparation of substituted 2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
CA2303594A1 (en) Compounds for treating and preventing diabetic complications
NO20044745L (no) 5-substituerte 1,1-diokso-1,2,5-tiazolidin-3-on-derivater som PTPASE 1B inhibitorer
UA92354C2 (en) Amino acid salts of rosiglitazone
WO2001087233A3 (en) Anti-idiotypic antibody against fimh adhesin of uropathogenic type i-fimbriated escherichia coli, compositions and method of use thereof
DK1395263T3 (da) 3, 7 eller 3 og 7 thia- eller oxaprostansyrederivater som midler til at sænke intraokulært tryk
EA200300842A1 (ru) Новая соль тиазолидиндиона и ее полиморфные формы в качестве противодиабетических средств и способ их получения
EA200200470A1 (ru) Новые производные тиазолидиндиона в качестве противодиабетических средств
EA200201055A1 (ru) Новый стабильный кристалл производного тиазолидиндиона и способ его получения
DE60227421D1 (de) Rmazeutische zusammensetzung und verwendung davon
PT1334094E (pt) Benzo[b]tiofenos e benzo(d)isotiazoles para diminuir o colesterol